Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 4, 2009, Pages

  Lee, Joon ^a   Stagg, Mark A ^a   Fukushima, Satsuki ^a   Soppa, Gopal K R ^a   Siedlecka, Urszula ^a   Youssef, Samuel J ^a   Suzuki, Ken ^a   Yacoub, Magdi H ^a   Terracciano, Cesare M N ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Cell electrophysiology; Cell therapy; Excitation contraction coupling; Heart failure; Paracrine mechanims

Indexed keywords

CALCIUM; CALCIUM CHANNEL L TYPE; GREEN FLUORESCENT PROTEIN; INDO 1; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CALCIUM CURRENT; CELL SIZE; CELL TYPE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; EXCITATION CONTRACTION COUPLING; FEMALE; GRAFT RECIPIENT; HEART CONTRACTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HYPOTHESIS; MONONUCLEAR CELL; MYOBLAST; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SARCOMERE; STEM CELL TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CALCIUM; CELL COMMUNICATION; CELL SIZE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; MALE; MYOBLASTS, SKELETAL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STROKE VOLUME; TISSUE THERAPY;

EID: 66249105698     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00931.2008     Document Type: Article

References (41)

1. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Honning CA, Zuba-Surma EK, Al Mallah M, Dawn B. Adult bone marrow- derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167: 989-997, 2007.
2. i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res 57: 1015-1024, 2003.
3. Balke CW, Shorofsky SR. Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res 37: 290-299, 1998.
4. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
5. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85: 1046-1055, 1992.
6. Cheng H, Song LS, Shirokova N, Gonzalez A, Lakatta EG, Rios E, Stern MD. Amplitude distribution of calcium sparks in confocal images: theory and studies with an automatic detection method. Biophys J 76:606-617, 1999.
7. Coppen SR, Fukushima S, Shintani Y, Takahashi K, Varela-Carver A, Salem H, Yashiro K, Yacoub MH, Suzuki K. A factor underlying late-phase arrhythmogenicity after cell therapy to the heart: global down- regulation of connexin43 in the host myocardium after skeletal myoblast transplantation. Circulation 118: S138-S144, 2008.
8. Del Monte F, Hajjar RJ, Harding SE. Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure. Circ Res 88: E66-E67, 2001.
9. Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 28: 208 -216, 2008.
10. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115: 572-583, 2005.
11. 2+ transient of failing human ventricular myocytes. Circ Res 84:435-444, 1999.
12. + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116: 1865-1877, 2006.
13. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79, 2003.
14. Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, Lee J, Barton PJ, Terracciano CM, Yacoub MH, Suzuki K. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 115: 2254-2261, 2007.
15. 2+ leak in heart failure: mere observation or functional relevance? Cardiovasc Res 77: 302-314, 2008.
16. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20: 661-669, 2006.
17. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219, 2008.
18. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276: 800-806, 1997.
19. Guan K, Hasenfuss G. Do stem cells in the heart truly differentiate into cardiomyocytes? J Mol Cell Cardiol 43: 377-387, 2007.
20. Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol 34: 951-969, 2002.
21. Huang F, Shan J, Reiken S, Wehrens XH, Marks AR. Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice. Proc Natl Acad Sci USA 103: 3456-3461, 2006.
22. Keung EC, Toll L, Ellis M, Jensen RA. L-type cardiac calcium channels in doxorubicin cardiomyopathy in rats morphological, biochemical, and functional correlations. J Clin Invest 87: 2108 -2113, 1991.
23. Kobayashi T, Hamano K, Li TS, Katoh T, Kobayashi S, Matsuzaki M, Esato K. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 89: 189-195, 2000.
24. Laflamme MA, Zbinden S, Epstein SE, Murry CE. Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol 2: 307-339, 2007.
25. Lee J, Stagg MA, Siedlecka U, Latif N, Soppa GK, Yacoub M, Terracciano CM. Identification of cell-specific soluble mediators and cellular targets during cell therapy for the treatment of heart failure. Regen Med 3: 953-962, 2008.
26. 2+ handling in the post-infarction rat heart. Cardiovasc Res 79: 42-51, 2008.
27. 2+ release. Circ Res 92: 904-911, 2003.
28. Murtuza B, Suzuki K, Bou-Gharios G, Beauchamp JR, Smolenski RT, Partridge TA, Yacoub MH. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 101: 4216-4221, 2004.
29. Nishijima Y, Sridhar A, Viatchenko-Karpinski S, Shaw C, Bonagura JD, Abraham WT, Joshi MS, Bauer JA, Hamlin RL, Gyorke S, Feldman DS, Carnes CA. Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy. Life Sci 81: 1152-1159, 2007.
30. Pouzet B, Vilquin JT, Hagege AA, Scorsin M, Messas E, Fiszman M, Schwartz K, Menasche P. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 71: 844-850, 2001.
31. 2+ exchanger in the rabbit. J Physiol 553: 229-242, 2003.
32. Rosenblatt JD, Lunt AI, Parry DJ, Partridge TA. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev Biol Anim 31: 773-779, 1995.
33. Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, Iaffaldano G, Padin-Iruegas ME, Gonzalez A, Rizzi R, Small N, Muraski J, Alvarez R, Chen X, Urbanek K, Bolli R, Houser SR, Leri A, Sussman MA, Anversa P. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci USA 104: 17783-17788, 2007.
34. Schroder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, Schwinger RH, Weil J, Herzig S. Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation 98: 969 -976, 1998.
35. Sun B, Leem CH, Vaughan-Jones RD. Novel chloride-dependent acid loader in the guinea-pig ventricular myocyte: part of a dual acid-loading mechanism. J Physiol 495: 65-82, 1996.
36. Suzuki K, Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, Lee J, Barton PJR, Terracciano CMN, Yacoub MH. Response to letter regarding article, "Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model". Circulation 116: E555, 2007.
37. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933, 1998.
38. Terracciano CM, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH. Clinical recovery from end-stage heart failure using left- ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 109: 2263-2265, 2004.
39. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42: 270-283, 1999.
40. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98: 1414-1421, 2006.
41. Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol 67: 69 -98, 2005.